Etsurou Hatano
23 Papers
1 Citations
Etsurou Hatano is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 15 publications.
Chat about Author
Papers
Protocol of the RACB study: a multicenter, single-arm, prospective study to evaluate the efficacy of resection of initially unresectable hepatocellular carcinoma with atezolizumab combined with bevacizumab
Masayuki Okuno,Takamichi Ishii,Akihiko Ichida,Akihiko Soyama,Nobuyuki Takemura,Seiko Hirono,Susumu Eguchi,T. Hasegawa,Yasuharu Sasaki,Kohei Uemura,Norihiro Kokudo,Etsurou Hatano +11 more
TL;DR: The RACB study is a prospective, single-arm, multicenter, phase II trial evaluating the efficacy of combination therapy with atezo’+ bev for conversion surgery in patients with technically and/or oncologically unresectable HCC.
10
Pancreatic RECK inactivation promotes cancer formation, epithelial-mesenchymal transition, and metastasis
Tomonori Masuda,Akihisa Fukuda,Go Yamakawa,Mayuki Omatsu,Mio Namikawa,Makoto Sono,Yuichi Fukunaga,Munemasa Nagao,Osamu Araki,Takaaki Yoshikawa,Satoshi Ogawa,Kenji Masuo,Norihiro Goto,Yukiko Hiramatsu,Yu Muta,Motoyuki Tsuda,Takahisa Maruno,Yuki Nakanishi,Toshihiko Masui,Etsurou Hatano,T. Matsuzaki,Makoto Noda,Hiroshi Seno +22 more
TL;DR: The authenticity of RECK as a pancreatic tumor suppressor is established, insights into its underlying mechanisms are provided, and the idea that RECK could be an important therapeutic effector against human PDAC is supported.
6
ELF3 suppresses gallbladder cancer development through downregulation of the EREG/EGFR/mTOR complex 1 signalling pathway.
Takeharu Nakamura,Yoshihiro Nishikawa,Masahiro Shiokawa,Haruhiko Takeda,Masataka Yokode,Shimpei Matsumoto,Yuya Muramoto,S. Ota,Hiroyuki Yoshida,H. Okada,Takeshi Kuwada,Saiko Marui,Tomoaki Matsumori,Takahisa Maruno,Norimitsu Uza,Yuzo Kodama,Etsurou Hatano,Hiroshi Seno +17 more
TL;DR: In this paper , the authors used a combination of autochthonous and allograft mouse models to study the effect of ETS transcription factor 3 (ELF3) on gallbladder cancer development.
5
Brg1 controls stemness and metastasis of pancreatic cancer through regulating hypoxia pathway
Osamu Araki,Motoyuki Tsuda,Mayuki Omatsu,Mio Namikawa,Makoto Sono,Yuichi Fukunaga,Tomonori Masuda,Takaaki Yoshikawa,Munemasa Nagao,Satoshi Ogawa,Kenji Masuo,Norihiro Goto,Yuko Muta,Yukiko Hiramatsu,Takahisa Maruno,Yuki Nakanishi,Sho Koyasu,Toshihiko Masui,Etsurou Hatano,Dieter Saur,Akihisa Fukuda,Hiroshi Seno +21 more
TL;DR: Bsg1 plays a critical role for cell survival, stem-like property and metastasis of PDAC through the regulation of hypoxia pathway, and thus could be a novel therapeutic target for PDAC.
5
Autophagy Inhibition Increased Sensitivity of Pancreatic Cancer Cells to Carbon Ion Radiotherapy.
Makoto Sudo,Hiroko Tsutsui,Shuhei Hayashi,Koubun Yasuda,K. Mitani,Makoto Anzai,Toshiro Tsubouchi,Mitsuaki Ishida,Sohei Satoi,Tatsuaki Kanai,Seiko Hirono,Etsurou Hatano,Jiro Fujimoto +12 more
TL;DR: In this paper , the authors performed carbon ion radiotherapy (CIRT) in human pancreatic cancer cell lines and analyzed their survival, apoptosis, necrosis, and autophagy.
4